Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly C Cushing

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
BMC Gastroenterology|May 22, 2024
Morning light treatment for inflammatory bowel disease: a clinical trialShirley Cohen-Mekelburg, Cathy A Goldstein, Muneer Rizvydeen, et al.
JHEP Reports : Innovation in Hepatology|May 16, 2022
Hepatic decompensation is accelerated in patients with cirrhosis and alpha-1 antitrypsin Pi∗MZ genotypeVincent L Chen, Daniel A Burkholder, Isabel J Moran, et al.
Inflammatory Bowel Diseases|January 12, 2022
Inflammatory Bowel Disease Risk Variants Are Associated with an Increased Risk of Skin CancerKelly C Cushing, Xiaomeng Du, Yanhua Chen, et al.
European Journal of Gastroenterology & Hepatology|August 18, 2020
Mapping the relationships between inflammatory bowel disease and comorbid diagnoses to identify disease associationsAkbar K Waljee, Mohamed Noureldin, Jeffrey A Berinstein, et al.
Nature Genetics|January 10, 2024
Comprehensive genetic study of the insulin resistance marker TG:HDL-C in the UK BiobankAntonino Oliveri, Ryan J Rebernick, Annapurna Kuppa, et al.
Journal of Crohn'S & Colitis|January 29, 2019
Novel Genetic Risk Variants Can Predict Anti-TNF Agent Response in Patients With Inflammatory Bowel DiseaseMing-Hsi Wang, Jessica J Friton, Laura E Raffals, et al.
Inflammatory Bowel Diseases|October 19, 2019
Unique Phenotypic Characteristics and Clinical Course in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis: A Multicenter US ExperienceMing-Hsi Wang, Omar Y Mousa, Jessica J Friton, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 28, 2021
Tofacitinib for Biologic-Experienced Hospitalized Patients With Acute Severe Ulcerative Colitis: A Retrospective Case-Control StudyJeffrey A Berinstein, Jessica L Sheehan, Michael Dias, et al.
JCI Insight|August 28, 2020
Contribution of plasma cells and B cells to hidradenitis suppurativa pathogenesisJohann E Gudjonsson, Lam C Tsoi, Feiyang Ma, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
BMC Gastroenterology|May 22, 2024
Morning light treatment for inflammatory bowel disease: a clinical trialShirley Cohen-Mekelburg, Cathy A Goldstein, Muneer Rizvydeen, et al.
JHEP Reports : Innovation in Hepatology|May 16, 2022
Hepatic decompensation is accelerated in patients with cirrhosis and alpha-1 antitrypsin Pi∗MZ genotypeVincent L Chen, Daniel A Burkholder, Isabel J Moran, et al.
Inflammatory Bowel Diseases|January 12, 2022
Inflammatory Bowel Disease Risk Variants Are Associated with an Increased Risk of Skin CancerKelly C Cushing, Xiaomeng Du, Yanhua Chen, et al.
European Journal of Gastroenterology & Hepatology|August 18, 2020
Mapping the relationships between inflammatory bowel disease and comorbid diagnoses to identify disease associationsAkbar K Waljee, Mohamed Noureldin, Jeffrey A Berinstein, et al.
Nature Genetics|January 10, 2024
Comprehensive genetic study of the insulin resistance marker TG:HDL-C in the UK BiobankAntonino Oliveri, Ryan J Rebernick, Annapurna Kuppa, et al.
Journal of Crohn'S & Colitis|January 29, 2019
Novel Genetic Risk Variants Can Predict Anti-TNF Agent Response in Patients With Inflammatory Bowel DiseaseMing-Hsi Wang, Jessica J Friton, Laura E Raffals, et al.
Inflammatory Bowel Diseases|October 19, 2019
Unique Phenotypic Characteristics and Clinical Course in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis: A Multicenter US ExperienceMing-Hsi Wang, Omar Y Mousa, Jessica J Friton, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 28, 2021
Tofacitinib for Biologic-Experienced Hospitalized Patients With Acute Severe Ulcerative Colitis: A Retrospective Case-Control StudyJeffrey A Berinstein, Jessica L Sheehan, Michael Dias, et al.
JCI Insight|August 28, 2020
Contribution of plasma cells and B cells to hidradenitis suppurativa pathogenesisJohann E Gudjonsson, Lam C Tsoi, Feiyang Ma, et al.
Pageof 3